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Persistent methicillin-resistant Staphylococcus aureus (MRSA) bacteremia (positive blood cultures after>7 days) represents a
challenging subset of invasive MRSA infections. The comparison of genome sequences of persistent (300-169) and resolving
(301-188) MRSA bacteremia isolates with similar genetic background (sequence type 45 [ST45]) will help us to better understand
underlying mechanisms of persistent MRSA bacteremia.
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Persistent methicillin-resistant Staphylococcus aureus (MRSA)bacteremia (PB) (positive blood cultures after7 days) com-
prises 20 to 30% of all episodes of MRSA bacteremia and is espe-
cially relevant to endovascular infections (1). The reasons why
someMRSA bacteremia strains persist while others resolve during
antimicrobial therapy despite similar clinical and microbiologic
characteristics are not well understood. Here we report the com-
plete genome sequences of PB (strain 300-169) and resolving
MRSA bacteremia (RB; negative blood cultures after 2 to 4 days of
therapy) (strain 301-188) clinical isolates with similar genetic
background (sequence type 45 [ST45]) which originated from a
multinational S. aureus bacteremia clinical trial collection (2).
While strain 300-169 was isolated from a patient with 16 days of
MRSA bacteremia, strain 301-188 was from a patient with 2 days
of MRSA bacteremia. The two strains were tested for several phe-
notypes that are thought to influence clinical outcomes. Strain
300-169 exhibited significantly better survival in the presence of
host defense cationic peptides, formed significantly more biofilm,
and induced significantly more endothelial cell damage than
strain 301-188. Both strains were similar in terms of virulence in a
rabbit infective endocarditis model, but in contrast to strain 301-
188, strain 300-169 was resistant to vancomycin therapy even
though both strains are susceptible to vancomycin in vitro (MIC,
0.5 g/ml for both strains) (3–6).
Purified genomic DNA was subjected to whole-genome shot-
gun sequencing by using a HiSeq system (Illumina, Inc.). Follow-
ing fragmentation, end reparation, and sample tagging, the se-
quencer produced 32.4 and 32.9 million paired reads for strains
300-169 and 301-188, respectively, yielding appreciable coverage
of ~1,000 for both strains. Assembly was performed using
Edena v. 140122 (7). Strain 300-169 assembly resulted in 37 con-
tigs (sum, 2.81 Mbp; N50, 469 kbp; maximum length, 1.0 Mbp),
while strain 301-188 assembly resulted in 40 contigs (sum,
2.76Mbp;N50, 412 kbp;maximum length, 598Kbp). Annotations
were performed by the NCBI Prokaryotic Genomes Annota-
tion Pipeline. The chromosome of strain 300-169 contains
2,620 coding sequences (CDSs), 22 rRNAs, and 60 tRNAs,
while the chromosome of strain 301-188 contains 2,539 CDSs,
25 rRNAs, and 60 tRNAs. For each strain, 52% of the genes
were assigned to specific subsystem categories by RAST (7).
Comparison of the two genomes revealed 137 single nucleotide
polymorphisms (SNPs).
Strain 300-169 contains one circular plasmid of 2.6 kb at an
apparent copy number of 25. Interestingly, 300-169 has a specific
bacteriophage of 44.2 kb and a highly mosaic prophage showing
partial homology with phi11, phi69 on the 5= extremity, and
phiSLT on the 3= end. Phages have been shown to play a role in
S. aureus pathogenicity by encoding diverse virulence factors or by
insertion into and thereby interruption of chromosomal S. aureus
virulence genes (i.e., -hemolysin [hlb] and lipase [geh] genes)
(8). The new phage in strain 300-169 is inserted in a metabolic
gene with hypothetical function involved in oxidoreduction reac-
tions. Importantly, phages can also influence genome plasticity
and thus adaptation to the host (8, 9). Studies to further examine
the gene contents and prophages that differ between the two iso-
lates and their roles in persistentMRSA bacteremia are in progress
in our laboratories.
Nucleotide sequence accession numbers. The whole-genome
sequences of MRSA 300-169 and 301-188 were deposited in the
DDBJ/EMBL/GenBank databases under the accession numbers
JASL00000000 and JASK00000000, respectively.
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